Lifecore Biomedical, Inc.
LFCR · NASDAQ
9/30/2025 | 5/25/2025 | 2/23/2025 | 11/24/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,991 | -$1,147 | -$14,769 | -$6,571 |
| Dep. & Amort. | $1,981 | $1,913 | $2,076 | $2,044 |
| Deferred Tax | $0 | $33 | -$9 | $109 |
| Stock-Based Comp. | $2,392 | $1,815 | $0 | $0 |
| Change in WC | $638 | -$1,026 | -$2,440 | -$8,696 |
| Other Non-Cash | $6,742 | $3,759 | $16,342 | $7,004 |
| Operating Cash Flow | $1,762 | $5,347 | $1,200 | -$6,110 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,737 | -$2,097 | -$5,456 | -$2,470 |
| Net Acquisitions | $0 | $0 | $7,000 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1,737 | -$2,097 | $1,544 | -$2,470 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$232 | -$2,631 | -$6,666 | -$10,940 |
| Stock Issued | $0 | -$8 | $17 | $23,840 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,156 | $2,237 | -$133 | -$385 |
| Financing Cash Flow | -$1,388 | -$402 | -$6,782 | $12,515 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,363 | $2,848 | -$4,038 | $3,935 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20,219 | $5,417 | $9,455 | $5,520 |
| End Cash | $18,856 | $8,265 | $5,417 | $9,455 |
| Free Cash Flow | $25 | $3,250 | -$4,256 | -$8,580 |